Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

9480	Companies
185535	Keywords
117927	Articles
99378	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 02/03/2025 at 15:35, 10 months 2 days ago

Jaguar Health Commences Pivotal Crofelemer Trial for SBS-IF and MVID

Crofelemer Clinical Trials Orphan Drugs MVID SBS-IF
PRESS RELEASE

published on 02/03/2025 at 15:30, 10 months 2 days ago

Jaguar Health Announces First Patient Dosed in Short Bowel Syndrome with Intestinal Failure in Investigator-Initiated Trial of Crofelemer; Proof-of-Concept Data Potentially Available H1 2025
Sheikh Khalifa Medical City hosts trial for Jaguar's crofelemer, plant-based drug granted Orphan Drug Designation. Study could lead to early patient access in Europe for rare diseases

Crofelemer Orphan Drug Designation SBS-IF Sheikh Khalifa Medical City Jaguar
BRIEF

published on 01/29/2025 at 14:35, 10 months 7 days ago

Jaguar Health Files Patent for Crofelemer to Address GI Side Effects

Crofelemer Jaguar Health GLP-1 Agonists GI Side Effects Weight Loss Therapy
PRESS RELEASE

published on 01/29/2025 at 14:30, 10 months 7 days ago

Jaguar Health Supports Evaluation of FDA-Approved Crofelemer to Address GI Side Effects of GLP-1 and Other Weight Loss Therapies: Files Patent Application with USPTO
Napo Pharmaceuticals files provisional patent application with USPTO for crofelemer, a novel plant-based drug to mitigate GI side effects of GLP-1 therapies

Crofelemer Plant-based Drug GLP-1 Therapies GI Side Effects Provisional Patent Application
BRIEF

published on 01/22/2025 at 15:05, 10 months 14 days ago

Jaguar Health Begins Trial for Crofelemer in Treating Rare Diseases

Jaguar Health Orphan Drug Designation MVID Crofelemer Trial SBS-IF
PRESS RELEASE

published on 01/22/2025 at 15:00, 10 months 14 days ago

Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial (IIT) Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease (MVID), with Proof-of-Concept (POC) Data Potentially Available H1 2025
Sheikh Khalifa Medical City hosts Jaguar Health's crofelemer trial for MVID & SBS-IF. POC data aims to support early patient access in EU countries

Crofelemer Jaguar Health MVID SBS-IF Sheikh Khalifa Medical City
BRIEF

published on 01/10/2025 at 22:20, 10 months 25 days ago

Jaguar Health Announces Inducement Grants for New Employees

Jaguar Health Employee Grants Nasdaq Rule Stock Units RSU Vesting
PRESS RELEASE

published on 01/10/2025 at 22:15, 10 months 25 days ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. granted RSUs to new employees, with vesting over one to three years. The RSUs were approved by Jaguar's Compensation Committee

Restricted Stock Units Jaguar Health Vesting RSUs New Employees
BRIEF

published on 01/08/2025 at 14:35, 10 months 28 days ago

Jaguar Health to Present at Upcoming Investor Events

Biotech Showcase Pharmaceuticals Jaguar Health Fireside Chat Investor Events
PRESS RELEASE

published on 01/08/2025 at 14:30, 10 months 28 days ago

Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
Jaguar Health, Inc. to participate in virtual fireside chat and in-person presentation at upcoming healthcare events. Focus on developing medicines from rainforest plants

Pharmaceuticals Jaguar Health Rainforest Plants Virtual Fireside Chat Healthcare Events

Accesswire

Published on 12/05/2025 at 19:50, 21 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 51 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 26 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 51 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 2 hours 11 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 13 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 45 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 56 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 19 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 25 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 53 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 11 hours 26 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 1 day 2 hours ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 1 day 2 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE